Biotechnology Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Biotechnology
NRX Pharmaceuticals Inc (NRXP) Q2 2024 Earnings Call Transcript Highlights: Significant Cost Reductions and New Funding Boost
NRX Pharmaceuticals Inc (NRXP) reports a nearly 10% reduction in net loss and secures $16 million in new funding, while advancing its clinical development pipeline. Aug 15, 2024
GuruFocus Research Biotechnology
Achieve Life Sciences Inc (ACHV) Q2 2024 Earnings Call Transcript Highlights: Key Financials, FDA Breakthrough, and ORCA-OL Trial Progress
Achieve Life Sciences Inc (ACHV) reports significant milestones and financial updates in its Q2 2024 earnings call. Aug 15, 2024
GuruFocus Research Biotechnology
Arcutis Biotherapeutics Inc (ARQT) Q2 2024 Earnings Call Transcript Highlights: Record Revenue Growth and Strategic Expansions
Arcutis Biotherapeutics Inc (ARQT) reports a 547% year-over-year revenue increase and significant advancements in product offerings and market reach. Aug 15, 2024
GuruFocus Research Biotechnology
Outlook Therapeutics Inc (OTLK) Q3 2024 Earnings Call Transcript Highlights: Key Financial Metrics and Strategic Updates
Discover the latest financial performance, strategic initiatives, and future outlook from Outlook Therapeutics Inc (OTLK) in their Q3 2024 earnings call. Aug 15, 2024
GuruFocus Research Biotechnology
Protalix BioTherapeutics Inc (PLX) Q2 2024 Earnings Call Transcript Highlights: Revenue Decline and Strategic Updates
Protalix BioTherapeutics Inc (PLX) reports a challenging quarter with decreased revenues but remains optimistic about future growth and strategic initiatives. Aug 15, 2024
GuruFocus Research Biotechnology
bluebird bio Inc (BLUE) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Expansions
bluebird bio Inc (BLUE) reports significant revenue increase and expanded treatment centers, but faces challenges in cash runway and revenue recognition timelines. Aug 15, 2024